Bio Pharma Dive
FEBRUARY 3, 2022
Executives for the pharma downplayed the impact of an accelerated approval for donanemab, pointing to Medicare's plans to restrict coverage of Alzheimer's drugs like it to only patients in clinical trials.
World of DTC Marketing
FEBRUARY 3, 2022
The way people make treatment decisions is changing because of COVID. Agencies are responsible for working with clients to implement changes that support brand objectives. It won’t be easy and means changing the mindset from a vendor to a strategic partner. If you work in an agency, your job is not to develop a website or TV spot. You need to work with pharma clients to educate them on the complicated path from awareness to requesting an Rx.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
FEBRUARY 3, 2022
Aduhelm sales totaled just $1 million in the fourth quarter as Biogen struggles to win over doctors and insurers. The company said it would reduce expenses by more than currently planned if Medicare limits coverage.
Pharma Mirror
FEBRUARY 3, 2022
Everybody knows that life as a caretaker can get rough sometimes, but it also comes with its fair share of benefits. In this article, we aim to highlight some of the long-term benefits of wearing scrubs to work, day in and day out. Being youthful at heart and work Depending on the scrub policy you have at your place of work, charcoal grey scrubs can add a completely new layer to your professional attire.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
FEBRUARY 3, 2022
Founded by University of California, Berkeley scientists, Rewrite is studying ways to expand the reach of gene editing beyond limitations of current technologies, including Intellia's.
Scienmag
FEBRUARY 3, 2022
New Jersey Institute of Technology (NJIT) has reaffirmed its status among the nation’s most elite and productive research institutions by once again achieving an R1 status — the highest designation — by the Carnegie Classification. Credit: NJIT New Jersey Institute of Technology (NJIT) has reaffirmed its status among the nation’s most elite and productive research […].
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
FEBRUARY 3, 2022
India’s Dr Reddy’s Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an undisclosed sum. While the regulatory framework for cannabinoid products remains fragmented and hard to navigate around the world, Germany has emerged as an early-mover.
Outsourcing Pharma
FEBRUARY 3, 2022
A leader from the artificial intelligence insights specialist talks discusses how the effective use of advanced analytics can lead to a number of benefits.
Intouch Solutions
FEBRUARY 3, 2022
Accolades Confirm Intouch as Among the Fastest-Rising Creative Agencies in the World. New York, NY — (Feb. 3, 2022) – Intouch Group, an EVERSANA company and a full-service global agency network serving the pharmaceutical industry, was ranked by Lürzer’s Archive as among the top five creative advertising agencies in the United States and top fifteen in the world.
pharmaphorum
FEBRUARY 3, 2022
Novartis chief executive Vas Narasimhan has downplayed any chances of swift decision on the future of its generics business Sandoz, saying that a decision on the possible sale of the unit may not come until the last quarter of the year. The comments came despite rumours of another private equity bid for Sandoz, with Bloomberg saying it had got wind of a $25 billion combined bid from investment groups Blackstone and Carlyle, with others including Advent International, Hellman & Friedman and K
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
FEBRUARY 3, 2022
Exoplanets come in shapes and sizes that are not found in our solar system. These include small gaseous planets called mini-Neptunes and rocky planets several times Earth’s mass called super-Earths. Credit: Image Credit: Adam Makarenko (Keck Observatory) Release Credit: NASA, ESA, STScI, Caltech, Keck Observatory Exoplanets come in shapes and sizes that are not found in our […].
pharmaphorum
FEBRUARY 3, 2022
Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post looks at dealing with sudden stress and turning it into positive energy. We’ve all been there: stomach revolting, heart pounding, hands moist.
Scienmag
FEBRUARY 3, 2022
URBANA, Ill. – Bikeshare systems have come a long way since they were first introduced in the Netherlands in the 1960s. They are popular in cities around the world, but how do bike systems affect existing public transportation? That’s the topic of a new paper from the University of Illinois, published in Transportation Research Part […].
pharmaphorum
FEBRUARY 3, 2022
Al Sandrock’s shock departure from Biogen in November sparked speculation about where he would show up next, and the answer came in today – gene therapy specialist Voyager Therapeutics. He has been appointed to Voyager Therapeutics’ board as well as a new executive committee alongside interim CEO Michael Higgins and interim chief scientific officer Glenn Pierce, another ex-Biogen executive.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
FEBRUARY 3, 2022
Many bacteria and unicellular algae have light-driven pumps in their cell membranes: proteins that change shape when exposed to photons such that they can transport charged atoms in or out of the cell. Thanks to these pumps, their unicellular owners can adjust to the environment’s pH value or salinity. Credit: Guillaume Gotthard and Sandra Mous […].
Pharma Times
FEBRUARY 3, 2022
Significant landmark as NICE recommends AstraZeneca's chronic kidney disease treatment Forxiga
Scienmag
FEBRUARY 3, 2022
Paris — Top-tier scientific journal Science today released a groundbreaking study of methane ultra-emitters linked to oil and gas activities that for the first time provides a statistical characterisation of these major drivers of climate change across various production activities. Credit: © Kayrros, Esri, HERE, Garmin, FAO, NOAA, USGS, OpenStreetMap contributors, and the GIS User […].
Pharma Times
FEBRUARY 3, 2022
Research collaboration between Parkinson’s UK and Domainex has potential to improve 140,000 lives
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
FEBRUARY 3, 2022
For decades, a small group of cutting-edge medical researchers have been studying a biochemical, DNA tagging system, which switches genes on or off. Many have studied it in bacteria and now some have seen signs of it in, plants, flies, and even human brain tumors. However, according to a new study by researchers at the […].
Outsourcing Pharma
FEBRUARY 3, 2022
The oncology centerâs Marie-JosÃe and Henry R. Kravis Cancer Ecosystems Project is intended to elevate the next generation of preclinical cancer research.
Scienmag
FEBRUARY 3, 2022
The World Health Organization projects that starting in 2030, over a million people will die each year from liver cancer. Cold Spring Harbor Laboratory (CSHL) Professor Adrian Krainer, former postdoc Wai Kit Ma, and Dillon Voss, a Stony Brook University M.D.-Ph.D. student-in-residence in Krainer’s lab, have come up with a way to interfere with the energy pathway that […].
BioPharma Reporter
FEBRUARY 3, 2022
The Coalition for Epidemic Preparedness Innovations (CEPI) has launched a Call for Proposals to improve the thermostability of vaccines: with a particular interest in temperature-stable vaccine nasal sprays, microarray patches, or orally administered vaccines.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
FEBRUARY 3, 2022
Thursday, February 3, 2022, CLEVELAND: Cleveland Clinic and Maria Shriver, founder of The Women’s Alzheimer’s Movement (WAM), announced a ground-breaking partnership today aimed at further addressing and reducing women’s risk for Alzheimer’s disease: The Women’s Alzheimer’s Movement at Cleveland Clinic (WAM at Cleveland Clinic). Credit: Cleveland Clinic Thursday, February 3, 2022, CLEVELAND: Cleveland Clinic and […].
BioPharma Reporter
FEBRUARY 3, 2022
AES Clean Technology, a supplier of cleanroom facilities for the pharmaceutical and biopharmaceutical sectors, is ploughing $14.2m into a new US manufacturing facility.
Scienmag
FEBRUARY 3, 2022
Vitamin D is most often recognized for its role in bone health, but low levels of the supplement have been associated with a range of autoimmune, cardiovascular, and infectious diseases. Early on in the pandemic health officials began to encourage people to take vitamin D, as it plays a role in promoting immune response and […].
pharmaphorum
FEBRUARY 3, 2022
The UK Competition and Markets Authority has ruled that several drugmakers worked together to raise the NHS price of widely-used nausea drug prochlorperazine, fining them £35 million ($47.5 million). Alliance Pharmaceuticals, Lexon, Medreich, and former and current owners of Focus – Advanz and private equity group Cinven – were involved in an agreement to fix the market for soluble prochlorperazine tablets, and raised the price they charged the NHS by 700%.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
FEBRUARY 3, 2022
Plants are at the bottom of the food chain and are continually threatened by pathogens and herbivorous insects. But the vast majority of attackers are unable to cause any damage due to a broadly based plant resistance, also known as non-host resistance. This resistance is permanent and effective. However, the mechanisms that lead to this […].
Drug Patent Watch
FEBRUARY 3, 2022
Annual Drug Patent Expirations for SPIRIVA+RESPIMAT Spiriva Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven…. The post New patent expiration for Boehringer Ingelheim drug SPIRIVA RESPIMAT appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
FEBRUARY 3, 2022
Maunakea, Hawai?i – Astronomers have identified two different cases of “mini-Neptune” planets that are losing their puffy atmospheres and likely transforming into super-Earths. Radiation from the planets’ stars is stripping away their atmospheres, driving hot gas to escape like steam from a pot of boiling water. Credit: W. M. Keck Observatory/Adam Makarenko Maunakea, Hawai?
Drug Patent Watch
FEBRUARY 3, 2022
Annual Drug Patent Expirations for RESTASIS Restasis is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are ten patents protecting…. The post New patent for Allergan drug RESTASIS appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
286 
Let's personalize your content